Flexible Work, Better Balance
Zymeworks is a global biotechnology company managing a portfolio of licensed healthcare assets and developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, including cancer, inflammation, and autoimmune disease. The company’s asset and royalty aggregation strategy focuses on optimizing positive future cash flows from an emerging portfolio of licensed products such as Ziihera® (zanidatamab‑hrii) and other licensed products and product candidates such as pasritamig. In addition, Zymeworks is building a portfolio of healthcare assets that can generate strong cash flows while supporting the early-stage development of innovative medicines. The company is headquartered in Vancouver, BC, with operations in Bellevue, WA, Dublin, IRE, and Singapore.
Nothing is more critical to our success than the quality of our team. The work we do is meaningful...